April 1, 2018 to September 30, 2018 net profit, a decrease in full in long-term loan repayment to financial institutions by Baht 40.36 million, and a Baht 45.24 million decline in trade and other payables
million, as a result of repayment of loans from financial institutions. page 3/…… - 3 - Net Profit In the Year 2018, the company recorded net profit attributable to equity holders of the company of Baht
and listed securities. While in 2018 the Company recorded a significant amount of unrealized loss from mark-to-market price of investment in listed equity securities, coupled with the loss on sale of
products wait for delivery and installation and decrease from the investment assets sold Baht 10.5 million. Total liabilities decreased 21.47% from the end of last year due to the repayment of personal loans
cost to sale of biological assets. Financial Cost Financial cost in Quarter 2/2019 was Baht 8.5 Million decreased by Baht 1.3 Million or 13.1% from Q2/2018 mainly from bank loan repayment in 2018. Net
will obtain the loan amount 50,000,000 Baht (Fifty Million Baht) without collateral or guarantee for a term of repayment not exceeding 2 months from the transaction date with interest rate at 4.83% per
million, as result of repayment of loans from financial institutions in June 2018. page 3/…… - 3 - Net Profit In the Quarter 2/2018, the company recorded net profit attributable to equity holders of the
million, as result of repayment of loans from financial institutions. Net Profit In the Quarter 3/2018, the company recorded net profit attributable to equity holders of the company of Baht 45.5 million
long-term loan repayment to financial institutions by Baht 49.72 million, and a Baht 20.51 million decline in trade and other payables, which was mainly บริษัท ดโีอด ีไบโอเทค จ ำกดั (มหำชน) 111 หมู่ที่ 2